Wells Fargo’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2K | Sell |
3,332
-13,346
| -80% | -$41K | ﹤0.01% | 5492 |
|
|
2025
Q1 | $32.2K | Sell |
16,678
-162,334
| -91% | -$313K | ﹤0.01% | 5089 |
|
|
2024
Q4 | $670K | Buy |
179,012
+25,225
| +16% | +$94.3K | ﹤0.01% | 3535 |
|
|
2024
Q3 | $752K | Buy |
153,787
+41,078
| +36% | +$201K | ﹤0.01% | 3379 |
|
|
2024
Q2 | $845K | Buy |
112,709
+100,803
| +847% | +$756K | ﹤0.01% | 3278 |
|
|
2024
Q1 | $296K | Buy |
+11,906
| New | +$296K | ﹤0.01% | 3874 |
|